Hexarelin
The most potent GHRP, used short-term for strength phases.
Emerging evidenceOverview
At a glance
Combining
Stacks well with: CJC-1295 (no DAC)
Avoid combining with: MK-677 (Ibutamoren)
Safety
Desensitization and prolactin rise with prolonged use.
Regulatory: Research/compounded.
Not appropriate if: cancer-history.
Questions
What makes hexarelin the most potent GHRP?⌄
It binds the ghrelin receptor with greater affinity than other GHRPs, producing the strongest GH pulse in the class. That potency is the reason it is typically reserved for short-term phases rather than ongoing use.
What is desensitization and why does it matter?⌄
With sustained use, the receptors hexarelin acts on down-regulate - they become less responsive to the signal. This reduces its effectiveness over time, which is why the cycle structure calls for short courses specifically.
How is hexarelin taken?⌄
As a subcutaneous injection at 100 mcg, one to two times daily, on an empty stomach. Exact protocol is set at your PepDepo consult.
What side effects should I know about?⌄
Prolactin can rise with prolonged use, and desensitization reduces effectiveness over time. Both are reasons to keep courses short and work within a structured protocol.
Who should not use hexarelin?⌄
Anyone with a cancer history. GH-axis stimulation is contraindicated in that population.
How does hexarelin differ from ipamorelin?⌄
Hexarelin is significantly more potent but less selective and prone to desensitization. Ipamorelin is the more sustainable, everyday option. Hexarelin is better suited to short targeted phases.
How long is a typical course?⌄
Short cycles, by design. The exact duration depends on your protocol and is determined at consult - it is shorter than the three to six month ranges common with other secretagogues.
Want a personalized protocol?
Exact dosing is set with a licensed provider in the PepDepo network. This page is education, not a prescription.
Book a consultEducation only, not medical advice. Peptides discussed are for informational purposes and many are not FDA-approved. Eligibility, prescribing, compounding, and dispensing are handled by appropriately licensed entities. Exact protocols and dosing are set with a licensed provider in the PepDepo network at consult. Content is pending clinical review.